Healthcare Research Report

smitatmr un-follow

The healthcare information technology industry deals with the storage, management, and exchange of healthcare records between hospitals, laboratories, patients, insurance agencies, and government bodies. The healthcare IT industry has seen exponential growth over the last few years, with the larger IT industry serving as the growth engine for the former. New advances in the information technology domain, coupled with the changing demands of patients and healthcare institutions, are combining to shape the future of the global healthcare information technology industry.

Pharmacovigilance Market: Detailed Analyses of Industry Trends 2018–2026

April 02, 2018 05:04AM, 0 comments

Pharmacovigilance is the science related to the valuation, detection, understanding, and prevention of adverse drug effects and other issue related to drugs. In response to the thalidomide disaster identified in 1961, WHO established its Program for International Drug Monitoring. WHO through its Collaborating Centre for International Drug Monitoring, Uppsala, promotes pharmacovigilance in different countries. Around 135 countries were a members of the WHO pharmacovigilance program in 2010. Pharmacovigilance aims at increasing patient safety related to the use of medicines in addition to supporting the public health programs by providing reliable information for effective assessment of the risk-benefit profile of medicines.

Request Sample of Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1729

The global pharmacovigilance market is anticipated to expand at a rapid pace during the forecast period owing to increase in incidence of adverse drug reactions. WHO report on pharmaceutical consumption stated that medicines used to treat chronic diseases held a large proportion of the total volume of drug consumption in the non-hospital sector. This has increased the number of medicines made available to health care consumers. Rise in drug consumption has significantly increased the need for new drug development. This, in return, is expected to drive the market. Key players in the pharmaceutical industry are involved in rigorous research & development activities to develop novel therapeutics. Companies are now aiming at transforming their product development process to meet patient requirement worldwide. These aspects are expected to increase demand for pharmacovigilance services during the forecast period. Moreover, leading pharmaceuticals companies in developed countries are focusing on outsourcing pharmacovigilance service to reduce cost and minimize operational expenses. This is anticipated to create opportunity for contract research organizations in developing regions. Companies are engaging strategic initiatives such as collaboration with the pharmacovigilance service providers to get access to medical information and manage pharmacovigilance workflows. For instance, in 2017, Accenture entered into a collaborative agreement with a leading pharmacovigilance service provider to develop a platform for the collection and investigation of clinical information for drug efficacy, thus improving its R&D proficiencies. These factors propel the pharmacovigilance market.

Read Report Overview: https://www.transparencymarketresearch.com/pharmacovigilance-market.html

The global pharmacovigilance market can be segmented based on phase of drug development, method, service provider type, service type, and region. In terms of phase of drug development, the market can be classified as preclinical phase or phase 0, clinical trial phase I, phase II trials, phase III trials, and phase IV trials or post-marketing surveillance phase. Based on method, the pharmacovigilance market can be categorized into intensified adverse drug reaction reporting, spontaneous reporting, cohort event monitoring, targeted reporting, and EHR mining. In terms of service provider type, the market can be divided into in-house, contract outsourcing, research institutes, and others. Based on service type, the pharmacovigilance market can be segregated into processing, signal detection, aggregate reporting, and others.

Download Brochure of Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1729

In terms of geography, the global pharmacovigilance market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominates the pharmacovigilance market owing to the rise in drug development activities by major players in the region. Europe accounts for the second largest share of the pharmacovigilance market. Rigid government policies and regulations for drug manufacturing procedure are likely to drive the pharmacovigilance market in Europe. The market in Asia Pacific is expanding at a rapid pace due to the rise in incidences of adverse drug reactions. Additionally, several local manufacturers are engaged in the development of generic drugs, especially in China and India. Therefore, it is important to have a stringent pharmacovigilance and drug safety monitoring program in these countries to ensure the public health safety. This fuels the pharmacovigilance market in the Asia Pacific. Middle East & Africa holds small share of the global market due to poor therapeutic facilities and less development of the pharmaceutical industry.

Key players in the global pharmacovigilance market are Accenture, Bristol-Myers Squibb, Cognizant, Pfizer Inc., Covance, Inc., F. Hoffmann-La Roche Ltd, GlaxoSmithKline plc, Wipro Limited, Novartis AG, IQVIA, Sanofi S.A., and Tata Consultancy Services Limited.

About us:

Transparency Market Research (TMR) is a U.S.-based provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

Contact us:

Transparency Market Research

90 State Street,

Suite 700,

Albany

NY - 12207

United States

Tel: +1-518-618-1030

USA - Canada Toll Free 866-552-3453

Email: sales@transparencymarketresearch.com

Website: http://www.transparencymarketresearch.com/

Read more..

Gene Delivery System Market Will be Worth US$ 4,281.0 Mn by 2025

March 29, 2018 12:03PM, 0 comments

Transparency Market Research (TMR) has published a new report titled “Gene Delivery System Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2017–2025”. According to the report, the global gene delivery system market was valued at approximately US$ 2,227.8 Mn in 2016 is projected to expand at a CAGR of over 7.8% from 2017 to 2025, The report suggests that increasing in incidence of chronic diseases, rise in technological advancement in administration of drug delivery are projected to boost the market from 2017 to 2025. Key players introduce advanced technologies for drug delivery systems in North America and Europe; therefore, these regions are likely to account for a dominant share of the global gene delivery system market. Changing lifestyle and increase in incidence of chronic diseases in emerging markets such as China and India are likely to boost the market in Asia Pacific. The market in the region is expected to expand at a CAGR of around 8.6% from 2017 to 2025.

Read Report Overview: https://www.transparencymarketresearch.com/gene-delivery-system-market.html

High Cost of Gene Delivery Systems is a Key Inhibitor for the Global Gene Delivery System Market

The cost of gene delivery system is significantly high, hence it is not affordable to all income groups. Additionally, lack of reimbursement in developing and under developed countries is likely to restrain the market. For instance, the cost of Spinraza, marketed by Biogen and used for the treatment of spinal muscular atrophy, is around US$ 750,000 per patient in the first year and US$ 375,000 annually thereafter. The cost of Cinryze, marketed by Viropharma used for the treatment of hereditary angioedema, is more than US$ 417,000 per patient per year. Moreover, rise in incidence of rare diseases increases the demand for treatment options. This, in turn, increases the cost of treatment due to less availability. Gene delivery targets only the affected region. Hence, stringent regulations lead to drug recalls. Therefore, gene delivery drugs are not sold over-the-counter.

Combined Hybrid Delivery System Segment to Lose Market Share

The report offers detailed segmentation of the global gene delivery system market based on delivery system, application, and route of administration. The delivery system is segmented into viral gene delivery system, non-viral gene delivery system, and combined hybrid delivery system. The combined hybrid delivery system segment is expected to lose market share during the forecast period primarily due to increase in demand for viral gene delivery system. Rise in incidence of genetic disorders with a different pattern of inheritance increases demand for gene delivery systems worldwide. Increase in application of viral gene delivery for the treatment of several chronic diseases such as cancer fuels the segment. The non-viral gene delivery system segment is likely to maintain market share during the forecast period. Several advantages of non-viral vectors over viral vectors such as lack of immunogenicity, low toxicity, and potential for tissue specificity drive the segment.

Request Sample of Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=41636

Urology Segment to Expand at Considerable Pace during the Forecast Period

Based on application, the oncology segment dominates the global gene delivery system. Increase in incidence of cancer worldwide, drives the segment. According to WHO report (2017), around 1 in 6 deaths occurs due to cancer globally. The urology segment accounted for market share of 7.0% in 2016. The segment is a projected to expand at a considerable pace due to increase in number of chronic kidney diseases and rise in incidences of kidney and liver cancer. According to World Kidney Day a global awareness campaign, 8% to 10% of adults have some form of kidney disorder globally.

Inhalation Segment to Lose the Market Share

In terms of route of administration, the injectable segment dominated the market with share of 43.8%. The injectable route of administration is used for rapid drug absorption. Drugs with low oral bioavailability are administered through intramuscular or subcutaneous route. The inhalation accounted for a small share of the market in 2016; however, is expected to lose market share during the forecast period. Drugs used for the treatment of lung diseases such as bronchodilators and steroids are administered through inhalation to achieve rapid action.

Download Brochure of Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=41636

Asia Pacific to Register Exponential Growth due to Increase in Incidence of Diseases

The market in Asia Pacific is expected to expand at a CAGR of 8.6% during the forecast period. Asia Pacific constituted 19.8% share of the market in 2016. Increase in incidence of several acute and chronic diseases in Asia Pacific drives the market in the region. India has high incidence of infectious diseases such as tuberculosis. According to WHO report (2015), India had 2.8 million tuberculosis patients, which was nearly 27.3% of global TB incidence, followed by Indonesia (9.8%), and China (8.8%). North America and Europe account for significant share of the global gene delivery system market due to increase in prevalence of cancer in these regions. According to WHO report 2016, 31% of all deaths were caused by cancer and 2% by diabetes in France.

Request For Discount On This Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=41636

Key Players such as Novartis AG, Amgen Inc., Oxford BioMedia plc, and SIBIONO to Lead the Global Gene Delivery System Market

Leading players operating in the global gene delivery system market include Novartis AG, Amgen Inc., Oxford BioMedia plc., SIBIONO, Shanghai Sunway Biotech Co. Ltd., Pfizer Inc., Bayer AG, Johnson & Johnson Services Inc., Human Stem Cells Institute, and Epeius Biotechnologies Corporation. Strong gene delivery system pipeline to drive the global gene delivery system market.

About us:

Transparency Market Research (TMR) is a U.S.-based provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

Contact us:

Transparency Market Research

90 State Street,

Suite 700,

Albany

NY - 12207

United States

Tel: +1-518-618-1030

USA - Canada Toll Free 866-552-3453

Email: sales@transparencymarketresearch.com

Website: http://www.transparencymarketresearch.com/

Read more..

Ophthalmology Surgical Devices Market Will be Worth US$ 11.0 Bn by 2025

March 29, 2018 12:03PM, 0 comments

The global ophthalmology surgical devices market was valued at approximately US$ 7,000.0 Mn in 2016 and is projected to register a compounded annual growth rate (CAGR) of over 4.0% from 2017 to 2025, according to a new report published by Transparency Market Research (TMR) titled “Ophthalmology Surgical Devices Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2017–2025”. The report suggests that technological advancements and presence of leading players is projected to augment the demand for ophthalmology surgical devices in the next few years (from 2017 to 2025). North America dominates the global ophthalmology surgical devices market, due to high preference for surgical procedures for eye treatment in the region. Emerging markets such as China, India, Argentina, and Brazil are likely to promote growth of the market in Asia Pacific and Latin America from 2017 to 2025.

Read Report Overview: https://www.transparencymarketresearch.com/ophthalmology-surgical-devices-market.html

Strategic Collaborations and High Unmet Needs for Refractive Surgeries to drive Global Ophthalmology Surgical Devices Market

Globally, disorders such as cataract, glaucoma, and age-related macular degeneration (AMD) are the leading causes of blindness and visual impairment. The burden of eye diseases across the globe is expected to increase significantly in the next few years. According to a report published by the World Health Organization (WHO) in 2010, cataract was responsible for causing blindness in 20 million people, which represented around 51% of the world blindness. Glaucoma was estimated to cause blindness in 4.5 million people, which was around 12% of the global blindness. The continuing worldwide demographic trend of people developing myopia is expected to augment the demand for refractive surgeries required to treat the disorder in the next few years. The rate of prevalence of myopia is as high as 70% or more in countries in East Asia. Companies in the ophthalmology surgical devices market are increasingly collaborating with one another as well as with research institutes in order to develop new technologies to address the current unmet needs for eye care. In May 2016, Bausch + Lomb and HOYA Surgical Optics entered into an exclusive agreement, which helped the former to market and commercialize the latter’s wide portfolio of injectors and intraocular lenses (IOLs) in the U.S.

Request Sample of Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=41633

Glaucoma Surgery Devices Segment to expand at a High Rate

The cataract surgery devices segment dominates the global ophthalmology surgical devices market in terms of revenue. Factors such as launch of new and innovative products, large number of patients with cataract, and government initiatives for promotion of cataract surgeries are likely to fuel the segment during the forecast period. The glaucoma surgery devices segment is estimated to expand at a CAGR of more than 4.0% during the forecast period. Factors such as rising adoption of minimally invasive glaucoma surgeries, increasing elderly population, and growing awareness among people are driving the glaucoma surgery devices segment. According to a study published by the American Academy of Ophthalmology, the prevalence of glaucoma in people aged 40–80 years in the U.S. was 64.3 million in 2013 and is set to increase to 76.0 million by 2020 and 111.8 million by 2040.

Hospitals Segment dominates in terms of Market Share

Based on end-user, the market has been classified into hospitals, ambulatory surgical centers, and ophthalmic clinics. The hospitals segment holds a major market share. The segment is estimated to expand at a CAGR of more than 4.0% during the forecast period. High preference for hospitals by patients with cataract and diabetic retinopathy, presence of a large number of hospitals with highly equipped technologies, and favorable health care insurance coverage are key factors driving the hospitals segment. The segment is likely to be followed by the ophthalmic clinics segment in the next few years. Increase in the number of ophthalmologists and independent optometrists is a key fueling factor for the ophthalmic clinics segment.

Download Brochure of Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=41633

Asia Pacific to offer High Incremental Opportunity

In terms of value, North America led the global ophthalmology surgical devices market in 2016. Rapid adoption for newer technologies and large pool of patients with eye diseases are factors responsible for the major share held by North America in the global market. However, various governments in the region are offering funds for R&D, encouraging pioneering research in the field of ophthalmic laser. Europe is the second-largest market for ophthalmology surgical devices. Increasing baby boomer population and rising incidence of eye disorders in the region are likely to propel the Europe ophthalmology surgical devices market during the forecast period. Increased participation of governments in the development of health care infrastructure and increasing disposable income of people in the region fuel the Asia Pacific ophthalmology surgical devices market. The market in Middle East & Africa was valued at approximately US$ 190.0 Mn in 2016 and is likely to expand at a CAGR of more than 3.0% from 2017 to 2025. Latin America and Middle East & Africa are likely to offer immense growth opportunities to the ophthalmology surgical devices market during the forecast period. Large number of cataract surgeries performed in countries such as Argentina and Bolivia, significant improvements, and initiatives by governments in these regions are factors that fuel the ophthalmology surgical devices market in Latin America and Middle East & Africa.

Request For Discount On This Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=41633

Key Players such as Alcon, Johnson & Johnson, Vision Care, Inc., and Carl Zeiss Meditec AG to continue to lead Global Ophthalmology Surgical Devices Market

The report also provides profiles of leading players operating in the global ophthalmology surgical devices market such as Alcon, Carl Zeiss Meditec AG, Johnson & Johnson Vision Care, Inc., Bausch & Lomb, Inc., IRIDEX Corporation, Lumenis Ltd., NIDEK CO., LTD., STAAR Surgical Company, HOYA Corporation, and Glaukos Corporation. Launch of new products and strengthening of product distribution channels across different geographies are key strategies adopted by several major players. Carl Zeiss Meditec AG aims to maintain balanced distribution of revenues across individual markets. The company currently generates around 33% of its revenues from the market in EMEA, the Americas, and APAC.

More Trending Reports by Transparency Market Research -

Shock Wave Therapy Device Market: https://www.prnewswire.com/news-releases/shock-wave-therapy-device-market-to-reach-us-1399-mn-by-2025-orthopedic-and-urology-application-leads-the-market-677627753.html

Veterinary Ultrasound Scanners Market: https://www.prnewswire.com/news-releases/veterinary-ultrasound-scanners-market-value-to-reach-us1794-million-by-the-end-of-2025-transparency-market-research-661812753.html

About us:

Transparency Market Research (TMR) is a U.S.-based provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

Contact us:

Transparency Market Research

90 State Street,

Suite 700,

Albany

NY - 12207

United States

Tel: +1-518-618-1030

USA - Canada Toll Free 866-552-3453

Email: sales@transparencymarketresearch.com

Website: http://www.transparencymarketresearch.com/

Read more..

Circular Dichroism Spectrometers Market Will be Worth US$ 51.0 Mn by 2025

March 29, 2018 11:03AM, 0 comments

The global circular dichroism (CD) spectrometers market was valued at approximately US$ 28.0 Mn in 2016 and is projected to register a CAGR of more than 6.0% from 2017 to 2025, according to a new report titled, “Circular Dichroism (CD) Spectrometers Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2017–2025” published by Transparency Market Research. The report suggests that technical advancement in CD spectroscopy, in terms of new modality, is expected to expand its applications, thereby boosting the demand for the product during the period, 2017 to 2025. As key players introduce their advanced CD spectrometers and new add-on accessories in the developed markets such a North America and Western Europe, these regions are projected to account for a dominating share of the global CD spectrometers market. Surge in public and private sector funding for R&D programs in the emerging markets such as China and India is projected to boost the growth of the CD spectrometers market in Asia Pacific at a CAGR of around 7.0% from 2017 to 2025.

Read Report Overview: https://www.transparencymarketresearch.com/circular-dichroism-spectrometers-market.html

Expanding applications of FDCD and Stopped Flow CD in proteomics study to boost CD spectrometer uptake

CD spectrometers are a type of analytical instrument used to study the molecular structure and chiral activity of biomolecules and other organic compounds. CD spectrometers are widely used in the study of proteins, DNA, and their conjugates. Earlier, CD spectrometers had limited applications which had restricted their adoption to academic institutes only. In recent times, key suppliers and researchers in CD spectrometers have developed new modalities of the product, such as fluorescence detected CD, magnetic CD, vibrational CD, circularly polarized luminescence (CPL), and stopped flow CD, which have supported researchers to perform in-depth study of biomolecule’s molecular structure and chiral activity at their ground state, photon excitation state, and also the impact of various factors such as temperature, pH, salinity, etc. on these attributes. As the pharmaceutical industry and researchers are hiking their R&D expenditure on new therapeutic entities such as biological drugs, demand for CD spectrometers is anticipated to surge up. However, CD spectrometer is an expensive capital equipment, which requires specialized infrastructure and skilled workforce. Moreover, use of alternative analytical tools such as Raman spectroscopy, Nuclear Magnetic Resonance (NMR) spectroscope, and X-ray crystallography is anticipated to restrain the uptake of CD spectrometers.

Request Sample of Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=41630

Multiple Light Source CD Spectrometers to Gain Market Share

The report offers detailed segmentation of the global circular dichroism (CD) spectrometers market based on product and end-user. Among the product types studied, the circularly polarized light sources segment is poised to account for the leading share of the global market during the forecast period from 2017 to 2025. The circularly polarized light sources CD spectrometers segment is expected to get a boost due to high demand for the product in the emerging markets; easy assembly and operation and comparatively low price of these spectrometers are the factors driving their market share. The multiple light sources CD spectrometers segment is anticipated to witness rapid expansion during the forecast period at a CAGR of around 7.0%. These CD spectrometers provide chiral activity’s study of a biomolecule at various wavelengths and in shorter time. The linearly polarized light sources segment is estimated to lose its market share during the forecast period from approximately 16.0% in 2016 to approximately 15.0% by 2025.

Download Brochure of Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=41630

Government and Private Research Organizations in Emerging Markets Poised to be Lucrative End-users

Among end-users, government and private research organizations are the leading contributors to the global CD spectrometers market. The segment is projected to constitute the dominant share of the global CD spectrometers market during the forecast period and is estimated to expand at a CAGR of around 7.0% from 2017 to 2025. Upsurge in funding from the public and private sectors for various research programs in developed markets is anticipated to propel this growth. Rising number of government and private institutes and universities in the emerging markets such as China, India, and Southeast Asia is estimated to fuel the market. Contract research organizations (CRO) is projected to be an emerging end-user segment of CD spectrometers in the emerging markets.

Asia Pacific to Resister Exponential Growth and Offer Huge Incremental Opportunity

In terms of value, North America was the leading contributor to the global circular dichroism (CD) spectrometers market in 2016. High public and private sector funding for research programs in the U.S. is one of the contributing factors toward the major share of the CD spectrometers market in the region. Stringent regulations and policies regarding documentation of the chiral nature of drug entities in the U.S. is leading the pharmaceutical industry and CROs to adopt analytical tools such as CD spectrometers. According to the National Center for Science and Engineering Statistics (NCSES), expenditure on R&D in the U.S. increased at a CAGR of 4% from 2013 to 2015. The trend is estimated to continue in the near future. Increasing cost of R&D processes and stringent rules and regulations for R&D in the developed regions such as the U.S. and Western Europe are compelling pharmaceutical companies to outsource their R&D activities to CROs in Asia Pacific. Moreover, initiatives undertaken by governing bodies in the region to develop higher education infrastructure is expected to fuel the CD spectrometers market in Asia Pacific at a CAGR of around 7.5% from 2017 to 2025.

Request For Discount On This Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=41630 \

Key Players such as AstraZeneca, Bayer AG and Merck & Co., Inc. are Likely to Continue to Lead the Global Cardiovascular Drugs Market

The report also provides profiles of leading players operating in the global circular dichroism (CD) spectrometers market such as Jasco, Applied Photophysics Ltd., Bio-Logic Science Instruments, Inc., Aviv Biomedical, Inc., On-Line Instrument Systems, Inc. (Olis), and Bruker. Most of these key players emphasize on development of new CD modalities such as fluorescence detected CD, stopped flow CD, vibrational CD, etc. These modalities are offered as an add-on accessory or standard feature of CD spectrometer. Expansion of geographic reach through collaborations and distribution agreements is a key strategy adopted by these key players; for example, Hinds Instruments, a manufacturer of photoelastic modulators, has developed microplate CD reader and licensed it to Bio-Logic Science Instruments, Inc. for global distribution.

More Trending Reports by Transparency Market Research -

Telemedicine Technologies and Services Market: https://www.prnewswire.com/news-releases/telemedicine-technologies-and-services-market-is-expected-to-expand-at-a-healthy-cagr-of-172-by-2023-globally-transparency-market-research-670699193.html

Point-of-care Diagnostics Market: https://www.prnewswire.com/news-releases/point-of-care-diagnostics-market-is-estimated-to-register-a-cagr-of-69-by-2024-globally-transparency-market-research-670895313.html

About us:

Transparency Market Research (TMR) is a U.S.-based provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

Contact us:

Transparency Market Research

90 State Street,

Suite 700,

Albany

NY - 12207

United States

Tel: +1-518-618-1030

USA - Canada Toll Free 866-552-3453

Email: sales@transparencymarketresearch.com

Website: http://www.transparencymarketresearch.com/

Read more..

Gynecological Devices Market Will be Worth US$22,589.9 mn by 2023

March 29, 2018 11:03AM, 0 comments

The global gynecological devices market is marked by a high degree of fragmentation due to the presence of several large and small manufacturers, reports Transparency Market Research (TMR) in a new business intelligence study. This leaves ample room for market consolidation in the near future. Nevertheless, top companies namely Boston Scientific Corporation, Cooper Surgical, and Olympus Corporation hold prominence on account of their extensive product portfolio and geographical outreach. These companies are vying to introduce non-invasive devices to serve a larger consumer base that will also help expand their geographical outreach. With increasing demand for medical help for women-centric health issues, there lies immense scope of growth for players in the gynecological devices market.

Read Report Overview: https://www.transparencymarketresearch.com/gynecological-devices-market.html

At present, small as well as regional players hold significant share in the gynecological devices market. However, increasing entry barriers and stringent regulations for product approval are limiting the entry of new companies. Insufficient funding from venture capitalists is also challenging new companies to enter this market.

As per projections of a TMR report, the global gynecological devices market will clock 4.8% CAGR between 2017 and 2023. This will translate opportunities in the market to generate a revenue of US$22,589.9 mn by 2023 from US$17,015.9 mn in 2017. In terms of device type, gynecological surgical devices hold prominence in the market. Rising prevalence of single incision laparoscopic surgeries and advances in conventional endoscopic surgeries account for advances in gynecological surgical instruments. Geography-wise, North America is a lucrative market for gynecological devices due to the early adoption of advanced gynecological devices.

Request Sample of Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=613

Efforts of Global Health Organizations for Women Health a Boon for Market

First and foremost, rising incidence of gynecological disorders such as uterine fibroids, cervical cancer, and menorrhagia is driving the gynecological devices market. In developing countries, healthcare infrastructural development and technologically advanced diagnostic services is favoring the gynecological devices market. An increasing awareness among women in these countries regarding therapeutics for gynecological diseases is also stoking demand for gynecological devices. Global health organizations and non-profit organizations conduct periodic health check-ups in developing and underdeveloped countries for women health. This stokes demand for gynecological devices.

In urban areas, modern lifestyle and increasing professional and personal stress are also related to gynecological conditions. This is necessitating routine check-up for women-centric health issues that may require gynecological devices at secondary stage of therapeutics.

Download Brochure of Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=613

Rising Preference for Minimally Invasive Procedures Stokes Demand

At present, acceptance of minimally invasive procedures generally is on the rise. This is because minimally invasive surgeries involve shorter hospital stay and faster recovery. Minimal scarring and ease of post-surgery care are leading individuals to opt for minimally invasive procedures. Gynecological surgery at one time meant big painful incisions, longer recovery periods, and intense monitoring. Due to this, open exposure surgical hysterectomies is increasingly being replaced with minimally invasive hysterectomies that involve the use of an electric morcellator surgical device.

Increasing public and personal healthcare expenditures and rising awareness of therapeutics for gynecological diseases in developing countries is cementing the growth of this market. Women health in these countries is increasingly being considered important for economic development thus drawing the attention of national governments.

Request For Discount On This Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=613

However, long hauls for product approval and delays for product approval from regulatory authorities is providing headwinds to the growth of gynecological devices market. Stringent documentation and compliance requirements delay commercial availability of advanced first-mover products.

About us:

Transparency Market Research (TMR) is a U.S.-based provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

Contact us:

Transparency Market Research

90 State Street,

Suite 700,

Albany

NY - 12207

United States

Tel: +1-518-618-1030

USA - Canada Toll Free 866-552-3453

Email: sales@transparencymarketresearch.com

Website: http://www.transparencymarketresearch.com/

Read more..

Advanced Wound Care Management Market Will be Worth US$11,161.6 mn by 2024

March 29, 2018 11:03AM, 0 comments

The worldwide market for advanced wound care management market is a consolidated one with a few companies that are technologically and scientifically advanced, reports Transparency Market Research (TMR) in a new report. The four top companies, namely Molnlycke Health Care, ConvaTec Group plc., Smith and Nephew, and Acelity L.P. Inc. held close to 65% market share in 2015. These topnotch companies are making significant investments in R&D so as to develop innovative products and stay in the lead. Competitive prices offered by top shots renders intense competition amongst them.

As per the TMR report, the global advanced wound care management market is likely to display a CAGR of 6.3% between 2017 and 2024. Expanding at this rate, the market which stood at US$7,268.1 mn will become worth US$11,161.6 mn by the end of 2024. Among the key product types, advanced wound dressings currently hold leading share in the overall market. Going ahead, the segment is likely to expand at the leading growth rate. Venous leg ulcers, on the basis of type of wound, holds the leading market share due to high incidence of leg ulcer cases.

Read Report Overview: https://www.transparencymarketresearch.com/advanced-wound-care-management-market.html

Rising Literacy in Developing Countries Accounting for Early Medical Help for Wounds Benefits Market

The advanced wound care management market is primarily driven by the rising incidence of chronic wounds. Chronic wounds generally require longer healing time and if not treated on time can lead to complications. Chronic wounds account for significant burden on public healthcare systems worldwide that have socioeconomic implications. According to statistics, currently more 4.5 million individuals suffer from pressure ulcers and more than 9.7 million individuals with venous ulcers.

Diabetic ulcers – a type of chronic wounds are growing at a rapid pace due to increasing incidence of Type 1 and Type 2 diabetes especially in developed economies. Diabetic ulcers is growing at 9% annually which outpaces the rate of development of new therapeutics. Patient pool of diabetic ulcer patients is currently close to 10.0 million.

Request Sample of Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=16139

Worldwide, growing elderly population above the age of 65 years is stoking demand for advanced wound care. As per statistics of the U.S. Census Board, individuals above the age of 65 years are estimated to account for 20% of the population by 2030. This population that is susceptible to falls and injuries require longer healing time that can impact quality of life and can also cause social distress. According to the Wound Healing Society, in the U.S., almost 15% individuals above the age of 65 years suffer from chronic wounds, which mainly include venous stasis ulcers, pressure ulcers, and diabetic foot ulcers.

Increasing patient awareness about early treatment of wounds is stoking demand for wound care products. Rising disposable income and increasing literacy especially in developing countries is leading individuals to seek early medical help for wounds before it leads to infection or other complications.

Download Brochure of Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=16139

Apart from this, commercial availability of different skin substitutes for treating chronic wounds is benefitting the advanced wound care management market. Skin substitutes help reduce healing time and reduce the risk of complications associated with burns, trauma, surgical cuts, and skin breakouts.

Limited Reimbursement Scenario Challenges Growth in the U.S.

On the downside, high cost of advanced wound care products over traditional wound dressing account for their limited adoption. For instance, in the U.S., the cost of managing pressure ulcer with advanced wound care products ranges from US$7,000 to US$55,000. Such costs are mostly affordable by the affluent thus makes for a smaller market. Limited reimbursement for advanced wound care products is a restrain to the growth of this market in the U.S.

About us:

Transparency Market Research (TMR) is a U.S.-based provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

Contact us:

Transparency Market Research

90 State Street,

Suite 700,

Albany

NY - 12207

United States

Tel: +1-518-618-1030

USA - Canada Toll Free 866-552-3453

Email: sales@transparencymarketresearch.com

Website: http://www.transparencymarketresearch.com/

Read more..

Flow Cytometry Market to Report a CAGR of 11.0% Between 2017 and 2025

March 23, 2018 10:03AM, 0 comments

The global flow cytometry market was valued over US$ 3,072 Mn in 2016 and is projected to register cumulative annual growth rate (CAGR) of over 11.0% from 2017 to 2025, according to a new report published by Transparency Market Research (TMR) titled “Global Flow Cytometry Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2017–2025”. The report suggests that rising demand for advanced medicine due increased chronic and acute diseases globally increasing the pharmaceutical researches and drug discovery operations is spurring the growth of flow cytometry in coming years (2017 to 2025).

Read Report Overview: https://www.transparencymarketresearch.com/flow-cytometry-market.html

The North America and Europe are projected to dominate the global flow cytometry market in the coming years owing to increase in manufacturer focus for business expansion in these regions. Players are continuously developing advanced flow cytometry instruments & products and entering into distribution agreements to fortify their footprints in the North American and European markets. Growing adoption of technologically advanced products manufactured by local manufacturers like Flowcytometry Solutions Pvt. Ltd. is likely to drive the Asia Pacific flow cytometry market. The Asia Pacific flow cytometry market is expected to witness CAGR of over 13% from 2017 to 2025

Flow Cytometry Instruments Dominates the Market Followed by Reagents & Consumables

The report offers detailed segmentation of global flow cytometry market based on technology, product & services, application, and end-user. Among the product & services segment, flow cytometry instrument segment is poised to account for leading share of the global market during the forecast period from 2017 to 2025. Factors attributed to the higher share of the reagent segment in the global market include increased the use of advance flow cytometry instruments in novel drug discovery, and targeted based drug discovery. Reagents & consumables segment is likely to register comparatively higher growth rate in terms of value in the global flow cytometry market during the forecast period owing to continuous innovations in the product technologies by major market players.

Request Sample of Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=40472

Pharmaceutical & Drug Discovery and Diagnostics: Top Two Application Areas of Flow Cytometry

Among applications, Pharmaceutical & Drug Discovery segment is projected to hold dominant share of global flow cytometry market during the forecast period and is likely to expand at CAGR more than 10% from 2017 to 2025. Major factors responsible for the dominance of this segment are continuous innovations in flow cytometry instruments and wide product portfolio of major as well as local manufacturers. For instance In October 2017 Sysmex America Inc. introduced CyFlow Antibodies for the application in clinical flow cytometry. Such continuous new product launches, along with exponentially rising patient base in developed as well as developing countries are likely to drive the segment between 2017 and 2025. According to JAMA oncology, in the year 2015 around 17.5 million new cancer cases was estimated globally, around 8.8 million death observed from cancer, which is nearly 1 in 6 deaths. Software and services segment, accounted for more than 28.0% share of global flow cytometry market in 2016, in terms of value.

Download Brochure of Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=40472

Growth of the Asia Pacific Flow Cytometry Market Likely To Be Hinged At China, Japan

In terms of value, North America was leading contributor in global flow cytometry market in 2016. Increased demand of flow cytometry products and increasing prevalence rate of immunological diseases such as HIV/AIDS among the population is the U.S. are some factors contributing for major share of the North America market. However, competition from image analyzer, scanning cytometers, dearth of skilled technician for data interpretation & technical implications are likely to hamper this market. Healthcare spending in emerging markets such as China and India are rising, which is fuelling the expansion of Asia Pacific flow cytometry market. Regaining economic growth in Latin American markets such as Brazil is augmenting healthcare expenditure through rise in private health insurance, entry of international drug manufacturers and health care providers in this region. This factor is likely to propel Latin America flow cytometry market at CAGR of 9% from 2017 to 2025.

Request For Discount On This Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=40472

Highly Consolidated Market with Top Three Players Accounting For More Than 50.0% of the Global Market

The report also provide profiles of leading players operating in global flow cytometry market Becton, Dickinson and Company (BD), Merck & Co., Inc., and Beckman Coulter, Inc. (Danaher) are major players operating in the market, offering wide range of products such as Becton, Dickinson and Company (BD) offers almost all the flow cytometry products includes instruments, software, antibodies, etc. Merck & Co., Inc. offers flow cytometry instruments, reagents kits, assay kits etc., while Beckman Coulter, Inc. (Danaher) offers advanced technological product as flow cytometry analyzer which offers infrared lasers and ultraviolet with avalanche photodiode sensors. Flowcytometry Solutions Pvt. Ltd. and Sysmex Partec GmbH are the other major players in the developed and developing countries, respectively. Expansion of flow cytometry product portfolio through partnerships to improve drug and biological product analysis is a growing trend in global flow cytometry market. For instance, on 17th January, 2018 Premas Life Sciences Pvt., Ltd. and IncellDx, Inc., signed agreement for diagnosis of solid tumor carcinoma that can now possible to analyzed for protein and molecular biomarkers by flow cytometry. Other prominent players in the global chemiluminescence immunoassay (CLIA) analyzers market include Thermo Fisher Scientific, Inc., Agilent Technologies, Inc., Bio-Techne., Alere, Inc. and Miltenyi Biotec GmbH.

About us:

Transparency Market Research (TMR) is a U.S.-based provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

Contact us:

Transparency Market Research

90 State Street,

Suite 700,

Albany

NY - 12207

United States

Tel: +1-518-618-1030

USA - Canada Toll Free 866-552-3453

Email: sales@transparencymarketresearch.com

Website: http://www.transparencymarketresearch.com/

Read more..

Wound Healing Market to Report a CAGR of 4.8% Between 2017 and 2025

March 23, 2018 10:03AM, 0 comments

The global Wound Healing market was valued at approximately US$ 23.3 Bn in 2016 is projected to register cumulative annual growth rate (CAGR) of over 4.8% from 2017 to 2025, according to a new report published by Transparency Market Research (TMR) titled “Wound Healing Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2017–2025”. The report suggests that increasing patient pool for chronic wounds is likely to spur the demand of wound healing products in the coming years (2017 to 2025). As key players introduce technologically advanced wound healing solutions in developed markets such a North America and Europe, these regions are likely to account for dominating share of the global wound healing market. Established presence & wide distribution networks of major players and growing market penetration of emerging players are likely to boost growth of Asia Pacific wound healing market at a CAGR of around 5.3% from 2017 to 2025.

Read Report Overview: https://www.transparencymarketresearch.com/wound-healing-market.html

High Cost of Advanced Wound Care Products to Restrain Global Market Expansion

According to the Centers of Disease Control (CDC) statistics, an estimated 450,000 – 500,000 patients suffer from burn injuries each year in the U.S. The direct costs of treatment of burn injuries in the U.S., was estimated to be around US$ 10.4 Bn. Wounds impose underappreciated burden on the population across the globe and they account for the majority of injuries related to skin. Rise in the prevalence of diabetes and obesity, and increasing adoption rate for wound care therapy devices in developed and emerging markets are likely to fuel the uptake of wound healing products by 2025. However, high price of newly launched and technologically advanced wound care products restricts their demand. Conventional wound healing products are preferred over technologically advanced costly dressings in the emerging economies, despite their slow healing process. The price sensitive market of developing nations thus restricts the growth of advanced wound management technologies, which in turn has attributed for devaluation of the market, thereby restraining growth of global wound healing market.

Request Sample of Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=40535

Wound Closure Agents to Lose Market Share

The report offers detailed segmentation of global Wound Healing market based on product, wound type, and gender. Among the product types studied, wound closure agents segment is poised to account for leading share of the global market during the forecast period from 2017 to 2025. Topical agents segment which comprises hemostatic agents, antimicrobials, wound cleansers, and others are likely to get boost from their ongoing R&D activities, in turn estimating highest number of new product launches in the near future. The wound closure agents segment is anticipated to lose its market share during the forecast period, and is expected to hold a share of 24.0% by 2025 from 28.1% in 2016. Availability of other advanced wound healing products with reduced risk of infection are factors likely to hamper the market share of this segment.

Chronic Wounds to Be the Most Promising Wound Type to Invest In

Among wound types, chronic wounds segment is projected to hold dominant share of global wound healing market during the forecast period and is likely to expand at CAGR of around 5.0% from 2017 to 2025. From chronic wounds, ulcers sub-segment is expected to lead the global wound healing market in terms of CAGR by 2025. As per the Agency for Healthcare Research & Quality (AHRQ), in U.S. US$ 9.0 Bn to US$ 11.0 Bn are spent on pressure ulcers by health care systems annually. Significant patient population, and availability of favorable reimbursement policies which are driving manufacturers’ focus on business expansion in advanced wound care products are projected to fuel this expansion. Significant economic burden of surgical site infections (SSI), and higher treatment costs associated with it is expected to propel the expansion of chronic wound segment during 2017-2025.

Download Brochure of Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=40535

Women are to Capture Relatively Significant Market Share during the Forecast Period

In case of women, especially in low and middle income countries, there is significant gap between reported and actual cases of diabetes and chronic wounds, which is anticipated to improve during forecast period. In terms of gender, women segment held 52.9% of global wound healing market share in terms of revenue. Initiatives such as Wound Awareness Week and other outreach programs are projected to increase the awareness in significant patient population.

Asia Pacific to Register Exponential Growth Rate and Offer Huge Incremental Opportunity

In terms of value, North America was leading contributor in global wound healing market in 2016. As per the data published by ‘Wound Care Awareness Week–2017’, the annual cost (including direct as well as indirect costs) of treatment of all types of wounds incurred to health care systems in the U.S. is US$ 50.0 Bn, while the annual cost of amputations exceeds US$ 8.0 Bn. High prevalence of chronic wound in this region is imposing significant economic burden and is increasing demand for affordable care in the U.S., which in turn is driving the growth of wound healing market in North America. Healthcare spending in emerging markets such as China and India are rising, which is fueling the expansion of Asia Pacific wound healing market. Geographical expansion of international players to this region through distribution and licensing agreements with local distributors in the region are anticipated to propel the growth of Asia Pacific in global wound healing market at CAGR of 5.3% from 2017 to 2025. Regaining economic growth in Latin America countries such as Brazil is augmenting healthcare expenditure through rise in private health insurance, entry of international wound healing products manufacturers & health care providers in this region. It is one of the major factor for the estimated growth of Latin America during 2017-2025.

Request For Discount On This Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=40535

Key Players such as Acelity L.P., Inc., Smith & Nephew plc, and Mölnlycke Health Care AB are Likely to Continue to Lead the Global Wound Healing Market

The report also provide profiles of leading players operating in global wound healing market include Smith & Nephew plc, Integra LifeSciences Corporation, B. Braun Melsungen AG, Mölnlycke Health Care AB, 3M Healthcare, Ethicon, Inc. (Johnson & Johnson), Hill-Rom Holdings, Inc., Cardinal Health, Acelity L.P., Inc., ConvaTec Inc., BSN medical (Svenska Cellulosa Aktiebolaget SCA), Coloplast Group, Medline Industries, Inc., Organogenesis Inc., and Hollister Incorporated. Expansion of wound healing portfolio by acquiring the wound healing platform of emerging players is a key strategy adopted by many key players.

About us:

Transparency Market Research (TMR) is a U.S.-based provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

Contact us:

Transparency Market Research

90 State Street,

Suite 700,

Albany

NY - 12207

United States

Tel: +1-518-618-1030

USA - Canada Toll Free 866-552-3453

Email: sales@transparencymarketresearch.com

Website: http://www.transparencymarketresearch.com/

Read more..

Sterility Testing Market Opportunity will Rise to US$ 1,500.0 Million by 2025

March 23, 2018 10:03AM, 0 comments

The global sterility testing market was valued at approximately US$ 750.0 Mn in 2016 is projected to register cumulative annual growth rate (CAGR) of over 7.0% from 2017 to 2025, according to a new report published by Transparency Market Research (TMR) titled “Sterility Testing Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2017–2025”. The report suggests that increase in research & development activities is outgrowth the demand of sterility testing in the coming years (2017 to 2025). North America dominating the sterility testing market due to establishment of new biopharmaceutical companies as well as quick adoption of advanced technology. The emerging markets such as China, India and Brazil is likely to boost growth of Asia Pacific and Latin America sterility testing market at a CAGR of more than 7.0% from 2017 to 2025.

Read Report Overview: https://www.transparencymarketresearch.com/sterility-testing.html

Technological Advancement and Strategic partnerships to Drive Global Sterility Testing Market

Technological improvements in devices and reagents available for sterility testing have aided in easing the process and contributed to market growth. This change in sterility requirements is an exciting development for the rapid microbial testing business. Manufacturers operating in the sterility testing market have entered into various strategic mergers & acquisitions and partnerships that enabled them to enhance market position and expand customer base. For instance, bioMérieux and Shimadzu have worked in partnership to develop their linear MALDI-TOF mass spectrometry technology for improved incorporation into the microbiology laboratory workflow. Similarly, BD Diagnostics and Bruker entered into a partnership to improve Bruker MALDI Biotyper for microbial identification and antimicrobial susceptibility testing.

Request Sample of Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=23714

Instruments and Biopharmaceutical Manufacturing Segment Market to Grow At High Rate

The kits and reagent segment dominate the sterility testing market in terms of revenue. The advantages of kits and reagents segment includes product affordability, easy product availability, increase in research and development activities and high awareness for kits and reagents are likely to fuel the growth of the segment. The instruments segment is the highly growing segment at a CAGR of more than 8.0%. Factors such as technological advancement, growing demand for automated products, favorable reimbursement scenario and rapid process are key factors driving the instruments segment. According to the European Federation of Pharmaceutical Industries & Associations, in 2016, the pharmaceutical sector in Brazil and China expanded at a growth rate of 10.0% and 6.9% respectively. The same year, the pharmaceutical sector in the European Union and the U.S. expanded at an average growth rate of 4.5% and 6.3% respectively. In terms of application sterility testing is highly preferred in biopharmaceutical manufacturing. Rising demand for high-quality and innovative products and growing prevalence of chronic diseases are key driving factors for the biopharmaceutical manufacturing segment.

Download Brochure of Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=23714

Traditional Sterility Tests Dominates In Term of Market Share

Sterility tests type is classified into traditional sterility tests and rapid sterility tests. In terms of test type traditional sterility tests contributes high market share. High acceptance among sterility testing service providers, high awareness about traditional sterility tests, low startup cost, high preference for membrane filtration tests are the key factors driving the traditional sterility tests segment. Rapid sterility tests is the highly growing segment at a CAGR of more than 8.0%. Increase in health care investment, technological advancements and rise in investment for research & development are expected to fuel the growth of the rapid sterility tests segment.

Asia Pacific to Offer Huge Incremental Opportunity

In terms of value, North America was leading contributor in global sterility testing market in 2016. Technological advancements, rapid adoption for newer technologies, and presence of a large number of providers of pharmaceuticals as well as medical devices are contributing factor for major share of the North America market. However launch of new, innovative products and an expanding skill base in North America implies that more people in the region will have access to advanced technology during the forecast period. Europe is the second largest market. Rise in research & development activities, increase in export of manufactured products to other countries are likely to accelerate Europe sterility testing market. The increase in number of pharmaceutical and biopharmaceutical companies and rising demand for drug products fueling the Asia Pacific sterility testing market. The Middle East & Africa region was valued at approximately US$ 27.1 Mn and likely to propel at a CAGR more than 6.5% from 2017 to 2025. Latin America and Middle East & Africa will create good market opportunity for sterility testing market. The increasing coverage of private health insurance coverage, rapid population growth, rise in prevalence of lifestyle diseases such as diabetes and cardiovascular disorders etc. are the factors fuel the rest of the Rest of the world sterility testing market.

Request For Discount On This Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=23714

Key Players such as Merck KGaA, bioMérieux, Inc and Thermo Fisher Scientific Inc., are Likely to Continue to Lead the Global Sterility Testing Market

The report also provide profiles of leading players operating in global sterility testing market include Merck KGaA, bioMérieux, Inc, Sartorius AG, Thermo Fisher Scientific Inc., Charles River Laboratories International, Inc., Solvias AG, Becton, Dickinson and Company, Rapid Micro Biosystems, Inc. Merger & acquisition activities, new product innovation are the the key strategy adopted by many key players. In July 2015, Celsis International, Ltd., a leading provider of rapid testing systems for bacterial contamination acquired by Charles River Laboratories International, Inc.

About us:

Transparency Market Research (TMR) is a U.S.-based provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

Contact us:

Transparency Market Research

90 State Street,

Suite 700,

Albany

NY - 12207

United States

Tel: +1-518-618-1030

USA - Canada Toll Free 866-552-3453

Email: sales@transparencymarketresearch.com

Website: http://www.transparencymarketresearch.com/

Read more..